0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Immune Globulins - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: September 2024
|
Report Code: QYRE-Auto-22V12021
Home | Market Reports | Health| Pharmacy
Global Immune Globulins Industry Research Report Growth Trends and Competitive Analysis 2022 2028
BUY CHAPTERS

Immune Globulins - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-22V12021
Report
September 2024
Pages:128
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Immune Globulins - Market Size

The global market for Immune Globulins was estimated to be worth US$ 15220 million in 2023 and is forecast to a readjusted size of US$ 25330 million by 2030 with a CAGR of 7.5% during the forecast period 2024-2030

Immune Globulins - Market

Immune Globulins - Market

Immune globulin (Ig) short-term protection against hepatitis A and measles
The market growth can be attributed to several factors. Firstly, the increasing prevalence of bleeding disorders, driven by factors such as genetic predisposition, aging population, and improved diagnostic capabilities, has fueled the demand for coagulation factor products. Additionally, advancements in recombinant DNA technology and biotechnology have enabled the development of highly purified and more effective coagulation factor concentrates, offering improved treatment options for patients.Furthermore, the rising awareness about bleeding disorders and the availability of comprehensive treatment programs have contributed to increased diagnosis rates and access to coagulation factor therapies. Improved reimbursement policies and healthcare infrastructure have also played a role in expanding market reach.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Immune Globulins, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Immune Globulins by region & country, by Type, and by Application.
The Immune Globulins market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Immune Globulins.
Market Segmentation

Scope of Immune Globulins - Market Report

Report Metric Details
Report Name Immune Globulins - Market
Forecasted market size in 2030 US$ 25330 million
CAGR 7.5%
Forecasted years 2024 - 2030
Segment by Type:
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Takeda, Grifols, CSL, Octapharma, Biotest, Kedrion, Hualan Bio, CNBG, Shanghai RAAS, CBPO, LFB Group, BPL, Sichuan Yuanda Shuyang
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Immune Globulins manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Sales, revenue of Immune Globulins in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Sales, revenue of Immune Globulins in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Immune Globulins - Market size in 2030?

Ans: The Immune Globulins - Market size in 2030 will be US$ 25330 million.

Who are the main players in the Immune Globulins - Market report?

Ans: The main players in the Immune Globulins - Market are Takeda, Grifols, CSL, Octapharma, Biotest, Kedrion, Hualan Bio, CNBG, Shanghai RAAS, CBPO, LFB Group, BPL, Sichuan Yuanda Shuyang

What are the Application segmentation covered in the Immune Globulins - Market report?

Ans: The Applications covered in the Immune Globulins - Market report are Immunodeficiency, Autoimmune Disease, Acute Infection

What are the Type segmentation covered in the Immune Globulins - Market report?

Ans: The Types covered in the Immune Globulins - Market report are IVIg Liquid, IVIg Powder

Recommended Reports

Immunoglobulin Market

Immune Therapeutics

Antibody Diagnostics

1 Market Overview
1.1 Immune Globulins Product Introduction
1.2 Global Immune Globulins Market Size Forecast
1.2.1 Global Immune Globulins Sales Value (2019-2030)
1.2.2 Global Immune Globulins Sales Volume (2019-2030)
1.2.3 Global Immune Globulins Sales Price (2019-2030)
1.3 Immune Globulins Market Trends & Drivers
1.3.1 Immune Globulins Industry Trends
1.3.2 Immune Globulins Market Drivers & Opportunity
1.3.3 Immune Globulins Market Challenges
1.3.4 Immune Globulins Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Immune Globulins Players Revenue Ranking (2023)
2.2 Global Immune Globulins Revenue by Company (2019-2024)
2.3 Global Immune Globulins Players Sales Volume Ranking (2023)
2.4 Global Immune Globulins Sales Volume by Company Players (2019-2024)
2.5 Global Immune Globulins Average Price by Company (2019-2024)
2.6 Key Manufacturers Immune Globulins Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Immune Globulins Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Immune Globulins
2.9 Immune Globulins Market Competitive Analysis
2.9.1 Immune Globulins Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Immune Globulins Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immune Globulins as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 IVIg Liquid
3.1.2 IVIg Powder
3.2 Global Immune Globulins Sales Value by Type
3.2.1 Global Immune Globulins Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Immune Globulins Sales Value, by Type (2019-2030)
3.2.3 Global Immune Globulins Sales Value, by Type (%) (2019-2030)
3.3 Global Immune Globulins Sales Volume by Type
3.3.1 Global Immune Globulins Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Immune Globulins Sales Volume, by Type (2019-2030)
3.3.3 Global Immune Globulins Sales Volume, by Type (%) (2019-2030)
3.4 Global Immune Globulins Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Immunodeficiency
4.1.2 Autoimmune Disease
4.1.3 Acute Infection
4.2 Global Immune Globulins Sales Value by Application
4.2.1 Global Immune Globulins Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Immune Globulins Sales Value, by Application (2019-2030)
4.2.3 Global Immune Globulins Sales Value, by Application (%) (2019-2030)
4.3 Global Immune Globulins Sales Volume by Application
4.3.1 Global Immune Globulins Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Immune Globulins Sales Volume, by Application (2019-2030)
4.3.3 Global Immune Globulins Sales Volume, by Application (%) (2019-2030)
4.4 Global Immune Globulins Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Immune Globulins Sales Value by Region
5.1.1 Global Immune Globulins Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Immune Globulins Sales Value by Region (2019-2024)
5.1.3 Global Immune Globulins Sales Value by Region (2025-2030)
5.1.4 Global Immune Globulins Sales Value by Region (%), (2019-2030)
5.2 Global Immune Globulins Sales Volume by Region
5.2.1 Global Immune Globulins Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Immune Globulins Sales Volume by Region (2019-2024)
5.2.3 Global Immune Globulins Sales Volume by Region (2025-2030)
5.2.4 Global Immune Globulins Sales Volume by Region (%), (2019-2030)
5.3 Global Immune Globulins Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Immune Globulins Sales Value, 2019-2030
5.4.2 North America Immune Globulins Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Immune Globulins Sales Value, 2019-2030
5.5.2 Europe Immune Globulins Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Immune Globulins Sales Value, 2019-2030
5.6.2 Asia Pacific Immune Globulins Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Immune Globulins Sales Value, 2019-2030
5.7.2 South America Immune Globulins Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Immune Globulins Sales Value, 2019-2030
5.8.2 Middle East & Africa Immune Globulins Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Immune Globulins Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Immune Globulins Sales Value
6.2.1 Key Countries/Regions Immune Globulins Sales Value, 2019-2030
6.2.2 Key Countries/Regions Immune Globulins Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Immune Globulins Sales Value, 2019-2030
6.3.2 United States Immune Globulins Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Immune Globulins Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Immune Globulins Sales Value, 2019-2030
6.4.2 Europe Immune Globulins Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Immune Globulins Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Immune Globulins Sales Value, 2019-2030
6.5.2 China Immune Globulins Sales Value by Type (%), 2023 VS 2030
6.5.3 China Immune Globulins Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Immune Globulins Sales Value, 2019-2030
6.6.2 Japan Immune Globulins Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Immune Globulins Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Immune Globulins Sales Value, 2019-2030
6.7.2 South Korea Immune Globulins Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Immune Globulins Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Immune Globulins Sales Value, 2019-2030
6.8.2 Southeast Asia Immune Globulins Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Immune Globulins Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Immune Globulins Sales Value, 2019-2030
6.9.2 India Immune Globulins Sales Value by Type (%), 2023 VS 2030
6.9.3 India Immune Globulins Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Takeda
7.1.1 Takeda Company Information
7.1.2 Takeda Introduction and Business Overview
7.1.3 Takeda Immune Globulins Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Takeda Immune Globulins Product Offerings
7.1.5 Takeda Recent Development
7.2 Grifols
7.2.1 Grifols Company Information
7.2.2 Grifols Introduction and Business Overview
7.2.3 Grifols Immune Globulins Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Grifols Immune Globulins Product Offerings
7.2.5 Grifols Recent Development
7.3 CSL
7.3.1 CSL Company Information
7.3.2 CSL Introduction and Business Overview
7.3.3 CSL Immune Globulins Sales, Revenue and Gross Margin (2019-2024)
7.3.4 CSL Immune Globulins Product Offerings
7.3.5 CSL Recent Development
7.4 Octapharma
7.4.1 Octapharma Company Information
7.4.2 Octapharma Introduction and Business Overview
7.4.3 Octapharma Immune Globulins Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Octapharma Immune Globulins Product Offerings
7.4.5 Octapharma Recent Development
7.5 Biotest
7.5.1 Biotest Company Information
7.5.2 Biotest Introduction and Business Overview
7.5.3 Biotest Immune Globulins Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Biotest Immune Globulins Product Offerings
7.5.5 Biotest Recent Development
7.6 Kedrion
7.6.1 Kedrion Company Information
7.6.2 Kedrion Introduction and Business Overview
7.6.3 Kedrion Immune Globulins Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Kedrion Immune Globulins Product Offerings
7.6.5 Kedrion Recent Development
7.7 Hualan Bio
7.7.1 Hualan Bio Company Information
7.7.2 Hualan Bio Introduction and Business Overview
7.7.3 Hualan Bio Immune Globulins Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Hualan Bio Immune Globulins Product Offerings
7.7.5 Hualan Bio Recent Development
7.8 CNBG
7.8.1 CNBG Company Information
7.8.2 CNBG Introduction and Business Overview
7.8.3 CNBG Immune Globulins Sales, Revenue and Gross Margin (2019-2024)
7.8.4 CNBG Immune Globulins Product Offerings
7.8.5 CNBG Recent Development
7.9 Shanghai RAAS
7.9.1 Shanghai RAAS Company Information
7.9.2 Shanghai RAAS Introduction and Business Overview
7.9.3 Shanghai RAAS Immune Globulins Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Shanghai RAAS Immune Globulins Product Offerings
7.9.5 Shanghai RAAS Recent Development
7.10 CBPO
7.10.1 CBPO Company Information
7.10.2 CBPO Introduction and Business Overview
7.10.3 CBPO Immune Globulins Sales, Revenue and Gross Margin (2019-2024)
7.10.4 CBPO Immune Globulins Product Offerings
7.10.5 CBPO Recent Development
7.11 LFB Group
7.11.1 LFB Group Company Information
7.11.2 LFB Group Introduction and Business Overview
7.11.3 LFB Group Immune Globulins Sales, Revenue and Gross Margin (2019-2024)
7.11.4 LFB Group Immune Globulins Product Offerings
7.11.5 LFB Group Recent Development
7.12 BPL
7.12.1 BPL Company Information
7.12.2 BPL Introduction and Business Overview
7.12.3 BPL Immune Globulins Sales, Revenue and Gross Margin (2019-2024)
7.12.4 BPL Immune Globulins Product Offerings
7.12.5 BPL Recent Development
7.13 Sichuan Yuanda Shuyang
7.13.1 Sichuan Yuanda Shuyang Company Information
7.13.2 Sichuan Yuanda Shuyang Introduction and Business Overview
7.13.3 Sichuan Yuanda Shuyang Immune Globulins Sales, Revenue and Gross Margin (2019-2024)
7.13.4 Sichuan Yuanda Shuyang Immune Globulins Product Offerings
7.13.5 Sichuan Yuanda Shuyang Recent Development
8 Industry Chain Analysis
8.1 Immune Globulins Industrial Chain
8.2 Immune Globulins Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Immune Globulins Sales Model
8.5.2 Sales Channel
8.5.3 Immune Globulins Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Immune Globulins Market Trends
    Table 2. Immune Globulins Market Drivers & Opportunity
    Table 3. Immune Globulins Market Challenges
    Table 4. Immune Globulins Market Restraints
    Table 5. Global Immune Globulins Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Immune Globulins Revenue Market Share by Company (2019-2024)
    Table 7. Global Immune Globulins Sales Volume by Company (2019-2024) & (K Units)
    Table 8. Global Immune Globulins Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Immune Globulins Price by Company (2019-2024) & (USD/Unit)
    Table 10. Key Manufacturers Immune Globulins Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Immune Globulins Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Immune Globulins
    Table 13. Global Immune Globulins Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immune Globulins as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Immune Globulins Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Immune Globulins Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Immune Globulins Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Immune Globulins Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Immune Globulins Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Immune Globulins Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
    Table 22. Global Immune Globulins Sales Volume by Type (2019-2024) & (K Units)
    Table 23. Global Immune Globulins Sales Volume by Type (2025-2030) & (K Units)
    Table 24. Global Immune Globulins Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Immune Globulins Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Immune Globulins Price by Type (2019-2024) & (USD/Unit)
    Table 27. Global Immune Globulins Price by Type (2025-2030) & (USD/Unit)
    Table 28. Global Immune Globulins Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Immune Globulins Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Immune Globulins Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Immune Globulins Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Immune Globulins Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Immune Globulins Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
    Table 34. Global Immune Globulins Sales Volume by Application (2019-2024) & (K Units)
    Table 35. Global Immune Globulins Sales Volume by Application (2025-2030) & (K Units)
    Table 36. Global Immune Globulins Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Immune Globulins Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Immune Globulins Price by Application (2019-2024) & (USD/Unit)
    Table 39. Global Immune Globulins Price by Application (2025-2030) & (USD/Unit)
    Table 40. Global Immune Globulins Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Immune Globulins Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Immune Globulins Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Immune Globulins Sales Value by Region (2019-2024) & (%)
    Table 44. Global Immune Globulins Sales Value by Region (2025-2030) & (%)
    Table 45. Global Immune Globulins Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
    Table 46. Global Immune Globulins Sales Volume by Region (2019-2024) & (K Units)
    Table 47. Global Immune Globulins Sales Volume by Region (2025-2030) & (K Units)
    Table 48. Global Immune Globulins Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Immune Globulins Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Immune Globulins Average Price by Region (2019-2024) & (USD/Unit)
    Table 51. Global Immune Globulins Average Price by Region (2025-2030) & (USD/Unit)
    Table 52. Key Countries/Regions Immune Globulins Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Immune Globulins Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Immune Globulins Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Immune Globulins Sales Volume, (2019-2024) & (K Units)
    Table 56. Key Countries/Regions Immune Globulins Sales Volume, (2025-2030) & (K Units)
    Table 57. Takeda Company Information
    Table 58. Takeda Introduction and Business Overview
    Table 59. Takeda Immune Globulins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 60. Takeda Immune Globulins Product Offerings
    Table 61. Takeda Recent Development
    Table 62. Grifols Company Information
    Table 63. Grifols Introduction and Business Overview
    Table 64. Grifols Immune Globulins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 65. Grifols Immune Globulins Product Offerings
    Table 66. Grifols Recent Development
    Table 67. CSL Company Information
    Table 68. CSL Introduction and Business Overview
    Table 69. CSL Immune Globulins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 70. CSL Immune Globulins Product Offerings
    Table 71. CSL Recent Development
    Table 72. Octapharma Company Information
    Table 73. Octapharma Introduction and Business Overview
    Table 74. Octapharma Immune Globulins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 75. Octapharma Immune Globulins Product Offerings
    Table 76. Octapharma Recent Development
    Table 77. Biotest Company Information
    Table 78. Biotest Introduction and Business Overview
    Table 79. Biotest Immune Globulins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 80. Biotest Immune Globulins Product Offerings
    Table 81. Biotest Recent Development
    Table 82. Kedrion Company Information
    Table 83. Kedrion Introduction and Business Overview
    Table 84. Kedrion Immune Globulins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 85. Kedrion Immune Globulins Product Offerings
    Table 86. Kedrion Recent Development
    Table 87. Hualan Bio Company Information
    Table 88. Hualan Bio Introduction and Business Overview
    Table 89. Hualan Bio Immune Globulins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 90. Hualan Bio Immune Globulins Product Offerings
    Table 91. Hualan Bio Recent Development
    Table 92. CNBG Company Information
    Table 93. CNBG Introduction and Business Overview
    Table 94. CNBG Immune Globulins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 95. CNBG Immune Globulins Product Offerings
    Table 96. CNBG Recent Development
    Table 97. Shanghai RAAS Company Information
    Table 98. Shanghai RAAS Introduction and Business Overview
    Table 99. Shanghai RAAS Immune Globulins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 100. Shanghai RAAS Immune Globulins Product Offerings
    Table 101. Shanghai RAAS Recent Development
    Table 102. CBPO Company Information
    Table 103. CBPO Introduction and Business Overview
    Table 104. CBPO Immune Globulins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 105. CBPO Immune Globulins Product Offerings
    Table 106. CBPO Recent Development
    Table 107. LFB Group Company Information
    Table 108. LFB Group Introduction and Business Overview
    Table 109. LFB Group Immune Globulins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 110. LFB Group Immune Globulins Product Offerings
    Table 111. LFB Group Recent Development
    Table 112. BPL Company Information
    Table 113. BPL Introduction and Business Overview
    Table 114. BPL Immune Globulins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 115. BPL Immune Globulins Product Offerings
    Table 116. BPL Recent Development
    Table 117. Sichuan Yuanda Shuyang Company Information
    Table 118. Sichuan Yuanda Shuyang Introduction and Business Overview
    Table 119. Sichuan Yuanda Shuyang Immune Globulins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 120. Sichuan Yuanda Shuyang Immune Globulins Product Offerings
    Table 121. Sichuan Yuanda Shuyang Recent Development
    Table 122. Key Raw Materials Lists
    Table 123. Raw Materials Key Suppliers Lists
    Table 124. Immune Globulins Downstream Customers
    Table 125. Immune Globulins Distributors List
    Table 126. Research Programs/Design for This Report
    Table 127. Key Data Information from Secondary Sources
    Table 128. Key Data Information from Primary Sources
List of Figures
    Figure 1. Immune Globulins Product Picture
    Figure 2. Global Immune Globulins Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Immune Globulins Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Immune Globulins Sales Volume (2019-2030) & (K Units)
    Figure 5. Global Immune Globulins Sales Price (2019-2030) & (USD/Unit)
    Figure 6. Immune Globulins Report Years Considered
    Figure 7. Global Immune Globulins Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Immune Globulins Players Sales Volume Ranking (2023) & (K Units)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Immune Globulins Revenue in 2023
    Figure 10. Immune Globulins Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. IVIg Liquid Picture
    Figure 12. IVIg Powder Picture
    Figure 13. Global Immune Globulins Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 14. Global Immune Globulins Sales Value Market Share by Type, 2023 & 2030
    Figure 15. Global Immune Globulins Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
    Figure 16. Global Immune Globulins Sales Volume Market Share by Type, 2023 & 2030
    Figure 17. Global Immune Globulins Price by Type (2019-2030) & (USD/Unit)
    Figure 18. Product Picture of Immunodeficiency
    Figure 19. Product Picture of Autoimmune Disease
    Figure 20. Product Picture of Acute Infection
    Figure 21. Global Immune Globulins Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 22. Global Immune Globulins Sales Value Market Share by Application, 2023 & 2030
    Figure 23. Global Immune Globulins Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
    Figure 24. Global Immune Globulins Sales Volume Market Share by Application, 2023 & 2030
    Figure 25. Global Immune Globulins Price by Application (2019-2030) & (USD/Unit)
    Figure 26. North America Immune Globulins Sales Value (2019-2030) & (US$ Million)
    Figure 27. North America Immune Globulins Sales Value by Country (%), 2023 VS 2030
    Figure 28. Europe Immune Globulins Sales Value (2019-2030) & (US$ Million)
    Figure 29. Europe Immune Globulins Sales Value by Country (%), 2023 VS 2030
    Figure 30. Asia Pacific Immune Globulins Sales Value (2019-2030) & (US$ Million)
    Figure 31. Asia Pacific Immune Globulins Sales Value by Country (%), 2023 VS 2030
    Figure 32. South America Immune Globulins Sales Value (2019-2030) & (US$ Million)
    Figure 33. South America Immune Globulins Sales Value by Country (%), 2023 VS 2030
    Figure 34. Middle East & Africa Immune Globulins Sales Value (2019-2030) & (US$ Million)
    Figure 35. Middle East & Africa Immune Globulins Sales Value by Country (%), 2023 VS 2030
    Figure 36. Key Countries/Regions Immune Globulins Sales Value (%), (2019-2030)
    Figure 37. Key Countries/Regions Immune Globulins Sales Volume (%), (2019-2030)
    Figure 38. United States Immune Globulins Sales Value, (2019-2030) & (US$ Million)
    Figure 39. United States Immune Globulins Sales Value by Type (%), 2023 VS 2030
    Figure 40. United States Immune Globulins Sales Value by Application (%), 2023 VS 2030
    Figure 41. Europe Immune Globulins Sales Value, (2019-2030) & (US$ Million)
    Figure 42. Europe Immune Globulins Sales Value by Type (%), 2023 VS 2030
    Figure 43. Europe Immune Globulins Sales Value by Application (%), 2023 VS 2030
    Figure 44. China Immune Globulins Sales Value, (2019-2030) & (US$ Million)
    Figure 45. China Immune Globulins Sales Value by Type (%), 2023 VS 2030
    Figure 46. China Immune Globulins Sales Value by Application (%), 2023 VS 2030
    Figure 47. Japan Immune Globulins Sales Value, (2019-2030) & (US$ Million)
    Figure 48. Japan Immune Globulins Sales Value by Type (%), 2023 VS 2030
    Figure 49. Japan Immune Globulins Sales Value by Application (%), 2023 VS 2030
    Figure 50. South Korea Immune Globulins Sales Value, (2019-2030) & (US$ Million)
    Figure 51. South Korea Immune Globulins Sales Value by Type (%), 2023 VS 2030
    Figure 52. South Korea Immune Globulins Sales Value by Application (%), 2023 VS 2030
    Figure 53. Southeast Asia Immune Globulins Sales Value, (2019-2030) & (US$ Million)
    Figure 54. Southeast Asia Immune Globulins Sales Value by Type (%), 2023 VS 2030
    Figure 55. Southeast Asia Immune Globulins Sales Value by Application (%), 2023 VS 2030
    Figure 56. India Immune Globulins Sales Value, (2019-2030) & (US$ Million)
    Figure 57. India Immune Globulins Sales Value by Type (%), 2023 VS 2030
    Figure 58. India Immune Globulins Sales Value by Application (%), 2023 VS 2030
    Figure 59. Immune Globulins Industrial Chain
    Figure 60. Immune Globulins Manufacturing Cost Structure
    Figure 61. Channels of Distribution (Direct Sales, and Distribution)
    Figure 62. Bottom-up and Top-down Approaches for This Report
    Figure 63. Data Triangulation
    Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

RELATED REPORTS

Global GLP-1 Targeted Peptide Weight Loss Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19A18322
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E3525
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35T3049
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33Y1801
Thu Sep 11 00:00:00 UTC 2025

Add to Cart